Company research
Urovant Sciences Ltd.
CIK 1740547Updated Sep 24, 2026
Securities
Historical securities (1)
UROV · NASDAQ · equity · closed Mar 26, 2021UROV price & chart
Historical security
This listing closed Mar 26, 2021. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
No filing activity has been returned.
Financials
FY 2020 · USDSource
Source
Source
balance sheet · annual statements
| Line item | FY 2020 | FY 2019 |
|---|---|---|
| ASSETS | ||
| AssetsUSD | 63,295,000Source | 100,121,000Source |
| Property, Plant and Equipment, NetUSD | 1,210,000Source | 923,000Source |
| Current assets: | ||
| Cash and Cash Equivalents, at Carrying ValueUSD | 51,414,000Source | 85,353,000Source |
| Assets, CurrentUSD | 58,318,000Source | 98,510,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 6,489,000Source | 12,914,000Source |
| Operating Lease, Right-of-Use AssetUSD | 3,135,000Source | — |
| LIABILITIES AND EQUITY | ||
| LiabilitiesUSD | 121,301,000Source | 25,351,000Source |
| Stockholders’ equity: | ||
| Common Stock, Value, IssuedUSD | 1,000Source | 1,000Source |
| Retained Earnings (Accumulated Deficit)USD | -322,276,000Source | -175,531,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 452,000Source | 269,000Source |
| Stockholders' Equity Attributable to ParentUSD | -58,006,000Source | 74,770,000Source |
| Additional Paid in Capital, Common StockUSD | 263,818,000Source | 250,032,000Source |
| Liabilities and EquityUSD | 63,295,000Source | 100,121,000Source |
| Current liabilities: | ||
| Liabilities, CurrentUSD | 30,931,000Source | 11,817,000Source |
| Operating Lease, Liability, CurrentUSD | 351,000Source | — |
| Accounts Payable, CurrentUSD | 1,589,000Source | 1,925,000Source |
| Operating Lease, Liability, NoncurrentUSD | 3,086,000Source | — |
| Additional Financial Items | ||
| Accrued Liabilities, CurrentUSD | 21,756,000Source | 9,877,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | — | 13,534,000Source |
cash flow · annual statements
| Line item | FY 2020 | FY 2019 |
|---|---|---|
| Cash flows from operating activities: | ||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -146,745,000Source | -111,346,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 20,483,000Source | 3,978,000Source |
| Changes in operating assets and liabilities: | ||
| Increase (Decrease) in Accounts PayableUSD | -336,000Source | 1,092,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -102,084,000Source | -109,036,000Source |
| Cash flows from investing activities: | ||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -769,000Source | -593,000Source |
| Cash flows from financing activities: | ||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 946,000Source | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 68,937,000Source | 188,631,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -33,916,000Source | 79,002,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 52,280,000Source | 86,196,000Source |
| Supplemental disclosure of cash flow information: | ||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 3,081,000Source | 169,000Source |
| Income Taxes Paid, NetUSD | 65,000Source | 178,000Source |
| Additional Financial Items | ||
| Share-based Payment Arrangement, ExpenseUSD | 20,483,000Source | 3,978,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | 675,000Source | 92,000Source |
| Foreign Currency Transaction Gain (Loss), UnrealizedUSD | -183,000Source | -262,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | -236,000Source | — |
| Gain (Loss) on Extinguishment of DebtUSD | -4,093,000Source | — |
| General and Administrative ExpenseUSD | 46,299,000Source | 18,585,000Source |
| Income Tax Expense (Benefit)USD | 65,000Source | 47,000Source |
| Net Income (Loss) Attributable to ParentUSD | -146,745,000Source | -111,346,000Source |
| Operating ExpensesUSD | 138,736,000Source | 110,783,000Source |
| Operating Lease, ExpenseUSD | — | 300,000Source |
| Other Nonoperating Income (Expense)USD | -34,000Source | — |
| Proceeds from Contributed CapitalUSD | 251,000Source | 41,631,000Source |
| Proceeds from Stock Options ExercisedUSD | 796,000Source | — |
income statement · annual statements
| Line item | FY 2020 | FY 2019 |
|---|---|---|
| Other Nonoperating Income (Expense)USD | -34,000Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -146,680,000Source | -111,299,000Source |
| Income Tax Expense (Benefit)USD | 65,000Source | 47,000Source |
| Net Income (Loss) Attributable to ParentUSD | -146,745,000Source | -111,346,000Source |
| Additional Financial Items | ||
| Current Income Tax Expense (Benefit)USD | 65,000Source | 47,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | 246,000Source | 180,000Source |
| General and Administrative ExpenseUSD | 46,299,000Source | 18,585,000Source |
| Interest Income (Expense), NetUSD | -3,581,000Source | -259,000Source |
| Operating ExpensesUSD | 138,736,000Source | 110,783,000Source |
| Operating Lease, ExpenseUSD | — | 300,000Source |
| Research and Development ExpenseUSD | 92,437,000Source | 92,198,000Source |